Schizophrenia-like psychosis and gitelman syndrome: a case report and literature review by Bing Pan et al.




and gitelman syndrome: a case report 
and literature review
Bing Pan1, Lijun Mou2*, Huichun Li1, Weibo Liu1 and Ying Hu2
Abstract 
Introduction: Gitelman syndrome(GS) is a rare inherited tubular disorder which is characterized by hypokalemia, 
metabolic alkalosis, hypomagnesemia, and hypocalciuria. Here, we report a case of schizophrenia-like psychosis con-
comitant with GS and related literatures are reviewed.
Case description: An 18-year-old male patient with 1-week history of auditory hallucinations, sense of insecurity, 
delusions of reference and feelings of being followed and controlled by others unknown, insomnia was admitted to 
Psychiatry department in December, 2013. Hypokalemia and hypomagnesemia were noted. He was diagnosed as 
schizophrenia-like psychosis. Treatment with paliperidone at the dose of 6 mg/day and magnesium and potassium 
supplementations was commenced. However, electrolyte disturbances failed to improve following psychosis remis-
sion. Therefore, other underlying diseases resulting in electrolyte disturbances were suspected. Along with hypoka-
lemia and hypomagnesemia, additional investigation showing metabolic alkalosis, hypocalciuria, renal loss of potas-
sium, were consistent with GS. Gene analysis revealed this patient carried out c. 2687 G > A homozygous mutation of 
exon 23 in the SLC12A3 gene which led to p.Arg896Gln. Eventually, GS was identified. Thus, additional spironolactone 
(40 mg/day) combined with increased doses of oral potassium chloride sustained-release tablets (3.0 g/day) and 
potassium magnesium aspartate (0.3 g/day) were administered. During next half a year, fatigue resolved, paliperidone 
gradually tapered and eventually discontinued while psychosis maintained complete remission. His serum potassium 
was near normal (3.2–3.5 mmol/L), hypomagnesemia significantly improved (0.57–0.67 mmol/L).
Discussion and evaluation: Electrolyte abnormalities secondary to GS might cause or contribute to development 
of neuropsychiatric symptoms. In turn, hypokalemia was common among acute psychiatric inpatients. As a conse-
quence, when concomitant with psychosis, GS was readily concealed.
Conclusion:   Electrolyte disturbances are common in acute psychiatric patients. However, when electrolyte distur-
bances are not improved following psychosis remission, other underlying diseases such as GS should be considered.
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Background
Gitelman syndrome(GS) is a  rare autosomal reces-
sive tubular disorder first described by Gitelman et  al. 
(1966). It is caused by mutation of SLC12A3 gene, which 
encodes the Sodium/Chloride co-transporter (NCCT) 
in the distal convoluted tubule (Simon et  al. 1996). GS 
is characterized by hypokalemia, metabolic alkalosis, 
hypomagnesemia and hypocalciuria. The majority of 
patients with GS do not present with symptoms until 
late childhood or adulthood (Naesens et al. 2004). Elec-
trolyte abnormalities secondary to GS may cause or con-
tribute to development of neuropsychiatric symptoms. In 
turn, hypokalemia is common among acute psychiatric 
patients (Lam et al. 2009). As a consequence, when con-
comitant with psychosis, GS is readily concealed. Here 
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we report a case of schizophrenia-like psychosis in a 
18-year-old boy with coexisting GS.
Case description
An 18-year-old boy with 1-week history of auditory hal-
lucinations, sense of insecurity, delusions of reference 
and feelings of being followed and controlled by others 
unknown, insomnia was admitted to Psychiatry depart-
ment in December, 2013. He often heard many boys and 
girls commenting on him and criticising him sometimes. 
He suspected people were always discussing him and 
doing harm to him. These symptoms mentioned above 
made him sometimes just stare blankly, feel nervous, 
restless, tired, irritable, afraid of going outside. Insom-
nia subsequently developed. He was previously healthy 
and had no remarkable family history. He was enrolled 
in a high school. He did not smoke, drink alcohol or 
use illicit drugs. After admission to the hospital, physi-
cal examination was normal. On mental state examina-
tion, the patient was oriented and cooperative. Positive 
and Negative Symptoms Scale (PANSS) scored 95 which 
indicated he was in acute psychosis. His full scale of 
Weschler Adult Intelligence was 98 which indicated his 
intelligence was normal. His electrocardiogram, brain 
magnetic resonance imaging were normal. The labora-
tory investigations showed hypokalemia (3.17  mmol/L), 
hypomagnesemia (0.48 mmol/L).
According to his symptoms and investigations, the 
patient was diagnosed with schizophrenia-like psy-
chosis and was treated with paliperidone at the dose of 
6  mg/day and magnesium and potassium supplementa-
tions. Two weeks later, anxiety ameliorated, quality of 
sleep improved, hallucination and delusion resolved. 
The PANSS scores decreased to 41.His serum potassium 
increased to 3.23  mmol/L, magnesium level was still at 
0.48 mmol/L. His electrolyte disturbances were thought 
to be caused by acute psychosis and were expected to 
recover soon, the patient was discharged with oral potas-
sium and magnesium supplementations.
During the regular following up, the patient felt a lit-
tle fatigue as before while his psychosis maintained 
complete remission. Two weeks later after discharge, 
laboratory studies showed worsened hypokalemia 
(2.99  mmol/L) and hypomagnesemia (0.49  mmol/L) 
despite potassium and magnesium supplementations. He 
had no history of diuretic, laxative and licorice intake, no 
episode of anorexia, vomiting and diarrhea. Considering 
that his psychosis and other common conditions failed to 
explain his electrolyte disturbances, we consulted a neph-
rologist who suspected this patient might had GS, further 
examinations were subsequently ordered. The results 
of hypokalemia, hypomagnesemia, metabolic alkalosis, 
hypocalciuria were consistent with GS (Table 1).
In order to verify this diagnosis, gene analysis was per-
formed. Genomic DNA was isolated and purified from 
peripheral blood of the subject and used for polymerase 
chain reaction (PCR) amplification of individual exons of 
the SLC12A3 gene. Twenty-six pairs of oligonucleotide 
primers were generated to amplify all 26 exons and flank-
ing intronic regions. PCRs were performed in a 50  μL 
volume containing 1  μL genomic DNA, 2  μL primers, 
1 μL deoxyribonucleotide triphosphate(dNTP), and 5 μL 
10 ×  9 Taq buffer, 5  μL MgCl2, 2.5 U Taq enzyme, and 
35.5 μL ddH2O. PCR was performed using standard con-
ditions with an initial denaturation step at 95 °C for 3 min, 
subsequently followed by 35 cycles with denaturation at 
94 °C for 30 s, annealing at 55–60 °C for 35 s and elonga-
tion at 72  °C for 40–50  s. Sanger direct sequencing was 
performed on an ABI 3730XL automated DNA sequencer 
(Applied Biosystems Division, Life Technologies, CA, 
USA) by Sangon Biotech Shanghai Co., (Shanghai, China). 
GenBank Accession Number NC_000016, was used as 
Table 1 Results of the laboratory investigations
Variable Reference range
Serum biochemistry
Sodium (mmol/L) 138.4 135 to 145
Potassium (mmol/L) 2.99 3.5 to 5.5
Urea (mmol/L) 4.10 2.80 to 7.2
Creatinine (μmol/L) 59 53 to 133
Fasting blood glucose (mmol/L) 4.51 3.89 to 6.11
Calcium (mmol/L) 2.37 2.08 to 2.60
Phosphate (mmol/L) 1.31 0.81 to 1.45
Magnesium (mmol/L) 0.49 0.73 to 1.06
Albumin (g/L) 52 35.0 to 52.0
Uric acid (μmol/L) 436 208 to 428
Alanine aminotransferase (U/L) 20 <45
Aspartate aminotransferase (U/L) 21 <35
Intact parathyroid hormone(pg/ml) 26.86 15.00 to 65.00
h-TSH (mIU/L) 4.17 0.35 to 4.94
Growth hormone (ng/mL) <0.05 <4.80
Aldosterone (standing, ng/L) 192.49 65.00 to 296.00
Plasma rennin activity (standing, μg/L/h) 0.29 0.93 to 6.56
Arterial blood gas
PH value 7.46 7.35 to 7.45
PaCO2 (mmHg) 46.7 36 to 44
Actual bicarbonate (mmol/L) 28.7 22 to 26
Base excess (mmol/L) 3.6 −3.0 to +3.0
Standard bicarbonate (mmol/L) 27.6 22 to 26
Urinalysis
PH value 7.49 4.6 to 8.0
Sodium (mmol/24 h) 238 65.00 to 296.00
Potassium (mmol/24 h) 114.9 25 to 100
Calcium to creatinine ratio (mmol/mmol) 0.058 >0.2
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reference sequences. The numbering of a nucleotide starts 
at the first adenine of the translation initiation codon. This 
patient carried out c. 2687 G > A homozygous mutation 
of exon 23 in the SLC12A3 gene which led to p.Arg896Gln 
which was already known as pathogenic mutation in the 
previous report (Kurschat et al. 2003) (Fig. 1).
Eventually, the diagnosis of GS was established. Thus, 
additional spironolactone (40  mg/day) combined with 
increased doses of oral potassium chloride sustained-
release tablets (3.0  g/day) and potassium magnesium 
aspartate (0.3 g/day) were administered. During next half 
a year, fatigue resolved, paliperidone gradually tapered 
and eventually discontinued while psychosis maintained 
complete remission. His serum potassium was near nor-
mal (3.2–3.5  mmol/L), hypomagnesemia significantly 
improved (0.57–0.67 mmol/L).
Discussion and evaluation
This patient with classical psychotic symptoms was diag-
nosed as schizophrenia-like psychosis at presentation. 
Hypokalemia and hypomagnesemia were noted. How-
ever, electrolyte disturbances failed to improve following 
psychosis remission which prompted us to suspect the 
electrolyte disturbances were caused by other underlying 
diseases. Eventually, GS was identified by gene analysis. 
To our knowledge, this is the first report of schizophre-
nia-like psychosis concomitant with GS.
GS is a rare disease which is initially considered as a 
mild type of the salt-losing tubular disorder (Sampath-
kumar et  al. 2010). A later study demonstrated that GS 
is not an asymptomatic disease. It adversely affects 
quality of life in patients with GS principally resulted 
from secondary electrolyte abnormalities, to at least the 
same degree as more significant diseases like hyperten-
sion, diabetes, and cardiac conditions (Cruz et al. 2001). 
Hypokalaemia alone was associated with the develop-
ment of central pontine myelinolysis which produced 
psychiatric symptoms such as changes in the level of con-
sciousness and behaviour or cognitive dysfunction (Bahr 
et al. 1990; Sugimoto et al. 2003). Hypomagnesemia also 
led to clinically significant signs and symptoms when 
serum levels fall below 0.5 mmol/L (1.2 mg/dL). Clinical 
manifestations of hypomagnesemia that promptly led to 
medical attention involve neuromuscular hyperexcitabil-
ity that may range from tremors, fascicula-tion, tetany, to 
convulsions, and neuropsychiatric disturbances includ-
ing apathy, delirium, and even coma (Pham et al. 2014). 
Therefore, psychosis and electrolyte abnormalities sec-
ondary to GS manifested overlapping symptoms which 
would conceal the coexistence of GS.
In turn, hypokalemia was common among acute psy-
chiatric patients (27.7  %), both agitation and the use of 
antipsychotics were postulated to contribute to the high 
prevalence of hypokalemia among acutely ill psychiatric 
patients (Lam et al. 2009). Antipsychotics were found to 
block the potassium efflux channel and prohibit intracel-
lular potassium from shifting into the extracellular com-
partment, they have been reported to cause hypokalemia 
when being taken in excess or overdose (Malik et  al. 
2005). Hypokalemia already developed before the usage 
of paliperidone and persisted after discontinuation, so 
hypokalemia was not caused by antipsychotics in this 
patient. Agitation was postulated to stimulate the surge 
of serum adrenaline, which via the over-stimulation of 
Fig. 1 The mutated sequence of NCCT polymerase chain reaction (PCR) fragment. The red circle indicates a homozygous c.2687 G > A mutation of 
exon 23 in SLC12A3 which led to p.Arg896Gln
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beta-adrenaline receptors, caused influx of potassium 
into cells (Lam et al. 1999). Under this condition, hypoka-
lemia might recover spontaneously following agitation 
remission. At first, we considered his electrolyte distur-
bance was only caused by agitation. But the electrolyte 
disturbances did not resolve after his psychosis remission 
which prompted us to investigate other causes. Eventu-
ally, the diagnosis of GS was established. With intensive 
potassium and magnesium supplementation and addi-
tional spironolactone, electrolyte disturbances signifi-
cantly improved.
Conclusion
Conclusively, electrolyte disturbances are common in 
acute psychiatric patients. However, when electrolyte dis-
turbances are not improved following psychosis remis-
sion, other underlying diseases such as GS should be 
considered.
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